3200威尼斯vip(中国)有限公司

News
NEWS
Home News Industry News
Breaking news! China's first national standard for human stem cells released in Chongqing!
2023-09-29

The 4th China Stem Cell and Regenerative Medicine Collaborative Innovation Platform Conference and the First Jinfeng Stem Cell Forum were held in Chongqing on the 23rd, and the conferenceofficially released China's first national standard for human stem cells, "Technical Specification for Management of Pluripotent Stem Cells in Biobanks" (GB/T42466-2023).

The release of this national standard marks that China now has standard technical support for stem cell biobank management, which is of great significance for promoting the standardized and normalized development of stem cell research and application in China, and also provides a pioneering demonstration for the formulation of subsequent related standards in the stem cell field.

"Technical Specification for Management of Pluripotent Stem Cells in Biobanks"It specifies the general technical requirements for the management of human pluripotent stem cells and mouse pluripotent stem cells in biobanks, including general principles, collection and receipt of raw materials and related data, line establishment, recovery and culture, freezing and storage, quality control, and management and technical requirements for distribution and transportation. This standard applies to the management of human pluripotent stem cells and mouse pluripotent stem cells in biobanks, and does not apply to the management of biological samples intended for clinical treatment.

"For the emerging field of stem cells, we already have group standards and international standards, and what is currently lacking is a national standard." Zhao Tongbiao, director of the Standard Working Committee of the Chinese Society for Cell Biology and head of the Standard Working Group of the China Stem Cell and Regenerative Medicine Collaborative Innovation Platform, introduced that the national standard released today plays a foundational, standardized, and normalizing role in the development of the entire stem cell field. He stated that the stem cell field is a forward-looking area in biotechnology, and once an emerging field forms standards, it also plays an important role in the development of other industries or fields.

Bian Xiuwu, academician of the Chinese Academy of Sciences and director of the Jinfeng Laboratory, stated that the national standard released this time, on the one hand, lets researchers and the public understand that the stem cell field needs standards and that stem cells should not be used casually; on the other hand, it allows research and development institutions to proactively build platforms and use stem cells in accordance with the standards to ensure safety and effectiveness.

He believes that stem cells themselves are seeds, but seeds also need standardized and normalized sources. "We hope to cooperate with the National Stem Cell Resource Center to establish a Southwest Stem Cell Resource Sub-center in Chongqing, based in Chongqing, to promote the standardized, standards-compliant, and compliant development of the stem cell industry."

"The ultimate hope for stem cells is to become new therapeutic methods or drugs beneficial to human health. At present, scientists around the world hope that stem cells can be used for treatment like traditional drugs, which requires standards." Ji Weizhi, academician of the Chinese Academy of Sciences, believes that at present, standards in the stem cell field still face great challenges, and the standards formulated today are the best result adapted to the current development period. With the in-depth development of stem cell theory and technology research, new standards will emerge in the future, and existing standards will also be continuously improved.

Share to:
Products
Cell Biology
Molecular Biology
Liquid Handling
Bioprocessing
Custom Products
Solutions
Biopharmaceuticals
Cell & Gene Therapy
Vaccines
Diagnostics & Testing
About Us
Company Profile
Corporate Culture
Development History
Honors & Qualifications
Contact Us
Service Hotline: 400-800-6815
Email: info@cellprobio.net
Address: Building 40, No. 18 Dongchang Road, Suzhou Industrial Park
[WeChat Account QR Code]
Copyright © 2023 Suzhou CellPro Biotechnology Co., Ltd. All rights reserved. Record No.:Su ICP No. 19059453-1
Baidu
sogou